Merck (MRK) Receivables - Other (2009 - 2023)

Merck (MRK) has 12 years of Receivables - Other data on file, last reported at $473.0 million in Q1 2023.

• Quarterly Receivables - Other fell 34.21% year-over-year to $473.0 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $473.0 million (down 34.21% YoY) and the FY2022 annual result came in at $511.0 million, down 46.99% from the prior year.
• Receivables - Other retreated to $473.0 million in Q1 2023 per MRK's latest filing, from $511.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $1.6 billion in Q2 2021 and bottomed at $473.0 million in Q1 2023.
• The 3-year median for Receivables - Other is $684.0 million (2022), against an average of $860.4 million.
• The widest annual swing landed in 2022, when Receivables - Other sank 59.5%; it then slumped 34.21% in 2023.
• Tracing MRK's Receivables - Other over 3 years: stood at $964.0 million in 2021, then tumbled by 46.99% to $511.0 million in 2022, then decreased by 7.44% to $473.0 million in 2023.
• Per Business Quant, the three latest MRK Receivables - Other figures stand at $473.0 million (Q1 2023), $511.0 million (Q4 2022), and $567.0 million (Q3 2022).

Peer Comparison